Table 1.

Patient's peripheral blood lymphocyte subpopulations 4 months after liver-small bowel transplantation*



Total lymphocytes, %

TCRαβ, %

TCRγδ, %
Marker
Patient
Control
Patient
Control
Patient
Control
CD3+  90.5 ± 2.4   73.0 ± 2.5   23.0 ± 4.7   93.0 ± 2.1   77.0 ± 4.7   6.5 ± 0.7  
CD3+ CD4 CD8  61.2 ± 6.2   3.1 ± 0.6   3.1 ± 2.7   0.3 ± 0.0   85.7 ± 5.1   1.1 ± 0.3  
CD3+ CD4+ CD8  1.8 ± 0.8   43.0 ± 2.6   97.1 ± 1.0   99.0 ± 1.6   6.3 ± 3.1   0.1 ± 0.0  
CD3+ CD4 CD8+  28.3 ± 2.5   27.0 ± 1.6   33.3 ± 2.1   93.0 ± 2.3   60.0 ± 5.6   6.3 ± 1.3  
CD3+ CD4 CD8αβ  10.6 ± 1.8   —   2.7 ± 0.6   —   87.5 ± 5   —  
CD3+ CD4 CD8αα  19.6 ± 1.1   —   87.7 ± 1.4   —   14.6 ± 4.1   —  
CD19+  2.2 ± 0.8   12.5 ± 1.4   —   —   —   —  
CD56+
 
1.9 ± 1.2
 
13.3 ± 1.6
 

 

 

 

 


Total lymphocytes, %

TCRαβ, %

TCRγδ, %
Marker
Patient
Control
Patient
Control
Patient
Control
CD3+  90.5 ± 2.4   73.0 ± 2.5   23.0 ± 4.7   93.0 ± 2.1   77.0 ± 4.7   6.5 ± 0.7  
CD3+ CD4 CD8  61.2 ± 6.2   3.1 ± 0.6   3.1 ± 2.7   0.3 ± 0.0   85.7 ± 5.1   1.1 ± 0.3  
CD3+ CD4+ CD8  1.8 ± 0.8   43.0 ± 2.6   97.1 ± 1.0   99.0 ± 1.6   6.3 ± 3.1   0.1 ± 0.0  
CD3+ CD4 CD8+  28.3 ± 2.5   27.0 ± 1.6   33.3 ± 2.1   93.0 ± 2.3   60.0 ± 5.6   6.3 ± 1.3  
CD3+ CD4 CD8αβ  10.6 ± 1.8   —   2.7 ± 0.6   —   87.5 ± 5   —  
CD3+ CD4 CD8αα  19.6 ± 1.1   —   87.7 ± 1.4   —   14.6 ± 4.1   —  
CD19+  2.2 ± 0.8   12.5 ± 1.4   —   —   —   —  
CD56+
 
1.9 ± 1.2
 
13.3 ± 1.6
 

 

 

 

 

Values presented as mean ± standard error of the mean (SEM). CD indicates cluster of differentiation; TCR, T-cell receptor; and —, not assessed.

*

Absolute lymphocyte number 1.65 × 109/L. Ninety-nine percent of CD3+ cells and 45% of CD19+ cells were of donor origin at the time of this analysis.

CD8αβ and CD8αα frequencies were not assessed on the control population.

or Create an Account

Close Modal
Close Modal